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Red blood cell aggregation in nephrotic syndrome. Red blood cell
(RBC) aggregation induced by fibrinogen is a major determinant of the
non-Newtonian flow behavior of human blood and has been suggested
as a possible contributing factor for thrombogenesis. Given the elevated
fibrinogen levels and the high incidence of thrombotic accidents in
nephrotic syndrome (NS), a study was designed to assess RBC aggrega-
tion in this disease. Three different aggregation assays were used: (1)
changes in light transmission through static cell suspensions, aggrega-
tion half time (AHT); (2) low gravity centrifugation of blood in nearly
vertical tubes, zeta sedimentation ratio (ZSR); (3) direct observation of
dilute RBC suspensions, microscopic aggregation index (MAT). The
results indicate that RBC aggregation, as measured by AHT and ZSR, is
increased significantly in NS patients versus healthy controls (P <
0.001 for both methods); this increase was not a function of renal
insufficiency. The AHT and ZSR data were well correlated with plasma
fibrinogen levels (r = 0.75 and 0.84, respectively). No differences were
observed with the MAI method, since with this technique the aggrega-
tion process reaches an asymptotic plateau for the range of fibrinogen
found in NS. Implications of increased RBC aggregation and thus
increased blood viscosity and flow disturbances on thrombogenesis are
discussed.
L'agregation erythrocytaire au cours du syndrome nephrotique. L' ag-
régation érythrocytaire induite par le fibrinogene est un determinant
majeur du comportement non-Newtonien du sang humain et son role
dans Ia thrombogenese a été suggéré. Etant donnés les taux élevés de
fibrinogene et Ia grande fréquence des accidents thrombotiques dans le
syndrome néphrotique (SN), une étude de l'agregation erythrocytaire a
etC entreprise dans cette maladie. Trois diffCrentes techniques d'Ctude
de l'agregation ont été utilisCes: (1) variations de Ia lumière transmise a
travers une suspension cellulaire au repos, temps de demi-agrCgation
(TDA); (2) centrifugation a faible gravité du sang dans un tube pratique-
ment vertical, rapport de sedimentation zeta (RSZ); (3) observation
directe d'une suspension diluée, index d'agrCgation microscopique
(JAM). Les résultats font apparaitre que l'agrégation erythrocytaire,
mesurCe par le TDA et le RSZ, est significativement augmentCe chez les
patients présentant un SN compares aux témoins sains (P < 0,001 par
les deux methodes); cette augmentation n'est pas liée a l'insuffisance
rCnale. Les donnes du TDA et du RSZ sont bien corrélées avec les taux
de fibrinogene (r = respectivement 0,75 et 0,84). Aucune difference n'a
été trouvé avec l'IAM car, par cette technique, l'intensité du processus
d'agrégation atteint un plateau maximum pour les valeurs de fibrino-
gene observées dans le SN. Les implications de cette augmentation de
l'agregation erythrocytaire donc de Ia viscosité sanguine et des modifi-
cations du flot sanguin sur Ia thrombogenese sont discutées.
Deep vein thrombosis is involved in about 30% of the patients
with nephrotic syndrome (NS) and, when located in renal veins,
can dramatically worsen renal disease [1—31. Several factors
leading to thrombosis in NS have been identified (for example,
elevated levels of plasma fibrinogen and factors V and VIII,
increased platelet counts), and there appears to be general
agreement that NS induces a hypercoagulable state favoring the
occurrence of thrombotic accidents [1—9]. Less attention has
been given, however, to the possible role of enhanced red cell
aggregation and thus altered blood rheology and blood flow as
possible contributory factors in the development of thrombosis
in this disease state. For example, increased blood viscosity
could promote flow stasis in the venous circulation, thereby
triggering the coagulation process by inducing local hypoxemia
and endothelial damage [10—12].
Erythrocyte aggregation results from bridging between adja-
cent red cells by specific plasma proteins (fibrinogen and serum
globulins) or colloids (high molecular weight dextran) adsorbed
to the cell surfaces [13, 14]; red blood cells (RBC) in isotonic
saline without these proteins or colloids do not demonstrate
cellular aggregation. The forces of aggregation due to macromo-
lecular adsorption and bridging are countered by the forces of
disaggregation due to mechanical shearing and electrostatic
repulsion between the charged surfaces of the adjacent cells
[13, 141. Thus, the degree of RBC aggregation depends on the
properties of the red cells as well as their external milieu.
Various experimental approaches to the study of RBC aggrega-
tion have been employed, including whole blood viscosity [15—
17], erythrocyte sedimentation rate (ESR) [18, 19], zeta sedi-
mentation ratio (ZSR) [19—22], direct observation of RBC
suspensions under different shear conditions [23, 24], light
transmission studies of cell suspensions [25], and microscopic
measurement of dilute RBC systems [261.
Given the elevated plasma fibrinogen concentrations found in
NS, increased RBC aggregation could be anticipated; a review
of the current literature, however, does not reveal studies
specific for this rheologic parameter. This investigation was
thus designed to measure the dynamics and steady state extent
of RBC aggregation for NS RBC in autologous plasma, NS RBC
in an isotonic dextran solution known to produce cell aggrega-
tion, and 0 Rh positive normal RBC in NS plasma. Our results
indicate a significant increase in RBC aggregation for NS RBC
in their own plasma; this aggregation showed a strong correla-
tion with plasma fibrinogen concentration. NS RBC aggregate-
like control cells in dextran solution and normal RBC in NS
plasma exhibit increased aggregation. These results suggest that
altered blood rheology caused by increased RBC aggregation
may be of importance in the etiology of thrombosis associated
with nephrotic syndrome.
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Table 1. Relevant general data for the nephrotic syndrome patients
Patient
no. Sex Age
Serum
albumin
g%
Urinary-
proteins
g124 hr
Serum
creatinine
mg%
Morphologic
diagnosis
1 M 65 2.4 3.8 0.8 MGN
2 F 30 1.9 8.0 0.9 ND
3 F 46 2.0 5.5 1.2 AMYL
4 M 30 2.2 7.6 1.2 MC
5 M 18 1.7 6.5 1.3 FGS
6 F 20 3.0 5.8 1.3 MC
7 M 59 3.3 3.3 1.3 LGN
8 F 19 2.3 6.5 1.4 LGN
9 M 73 3.4 9.0 1.9 ND
10 M 67 3.2 6.2 2.1 ND
11 F 69 2.8 6.2 2.5 FGS
12 M 50 2.0 4.0 2.6 MPGN
13 M 24 2.4 14.0 2.6 LGN
14 M 66 2.8 5.2 2.7 ND
15 M 49 3.3 6.0 3.3 MPGN
16 F 35 2.4 5.1 3.5 ND
17 M 72 2.4 5.0 4.3 ND
18 M 45 2.9 5.0 5.2 ND
19 M 51 3.3 4.0 6.7 LUN
20 M 22 3.1 11.5 6.7 ND
21 M 50 2.7 6.3 10.0 ND
Abbreviations: MGN, membranous glomerulonephritis; MC, minimal change; AMYL, amyloidosis; MPGN, membranoproliferative glomerulo-
nephritis; LGN, lupic glomerulonephritis; FGS, focal glomeruloscierosis; ND, not done.
Methods
Blood and RBC suspensions. Blood samples from 21 nondia-
betic NS patients were studied with the approval of the Univer-
sity of Southern California Human Subjects Research Commit-
tee; all were admitted to the Los Angeles County-University of
Southern California Medical Center. Table 1 indicates relevant
general data for these -patients. Their average age was 46 years
(SD = 19 years, range 18 to 73, 14 males and 7 females), and all
had clinical and biological features of NS (mean proteinuria =
6.3 g/24 hr, mean serum albumin = 2.6 g%). Eight of the 21
patients (numbered 1 through 8) had normal renal function
(serum creatinine < 1.4 mg%), while the 13 others had serum
creatinine concentrations ranging from 1.9 to 10 mg%. Five of
the 21 patients (numbered 7, 9, 10, 19, and 20) had serum
albumin concentrations slightly greater than the nominal 3.0 g%
level and were not in remission.
Control blood samples were obtained from 18 hematological-
ly normal adult donors with an average age of 32 years (SD = 7
years, range 22 to 42, 7 males and 11 females).
Blood samples were collected via venipuncture into heparin
(5 lU/mi). RBC were isolated by centrifugation at X2000g for 10
mm, and, via gentle aspiration, the plasma was removed and the
buffy coat was discarded. The cells were washed once via
centrifugation-aspiration in an isotonic phosphate-buffered sa-
line solution (PBS, 0.03 M KH2PO4 + Na2HPO4, 290 mOsm/kg,
pH 7.42 at 25°C). Following this wash, the RBC were resus-
pended in either autologous plasma or in a strongly aggregating
[27] 1% dextran-PBS solution (500,000 daltons T-500, lot FR
13748, Pharmacia Co., Uppsala, Sweden); the pH and osmolali-
ty of this dextran-PBS solution were measured to be 7.42 and
291 mOsmlkg. RBC from one of the control donors (0 Rh
positive cells) were also resuspended in the plasma from both
the NS patients and the controls to evaluate the specific role of
plasma in the aggregation process. The hematocrit of these
suspensions was adjusted as appropriate for the aggregation test
employed (45% for the aggregation half time and zeta sedimen-
tation ratio or 0.7% for the microscopic aggregation index, see
below). All measurements were made at room temperature (22
1°C) within 4 hr after blood collection.
Measures of RBC aggregation
Three separate methods were used to assess the aggregation
tendency of RBC in the various suspensions. Inasmuch as the
details of these techniques have been published elsewhere, only
a limited description of each is provided below.
Aggregation halftime (AHT). The dynamics of RBC aggrega-
tion at zero shear rate were measured using the light transmis-
sion method of Schmid-SchOnbein et al [28]. This technique is
based on the increase of light transmission through a RBC
suspension which occurs when individual RBC aggregate into
rouleaux or rouleaux-rouleaux complexes; suspending medium
gaps between the cell aggregates produce the increased light
transmission.
Light transmission studies were done using a counter-rotating
cone-plate Rheoscope system [25] consisting of a transparent
glass plate and a transparent, plastic, 1.5° cone. The cone and
the plate are rotated, in opposite directions, via a servo-
controlled DC motor; variation of their rotational speed allows
the shear rate in the gap between the cone and the plate to be
changed. Observations were always made at a radial distance of
1,150 j.t from the center of rotation, thus providing, at this
distance, a 30-p gap between these two counter-rotating sur-
faces. The Rheoscope is mounted on the stage of an inverted
microscope (Leitz Diavert, Leitz, Wetzlar, Germany) and the
optical path illuminated, at 600 m, by a low voltage bulb
powered by a stabilized DC power supply. The light source of
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the microscope passes through the cone-plate portion of the
Rheoscope to a photocell which replaces the usual eyepiece.
The photocell voltage, V, is amplified and recorded on a strip
chart recorder operating at a paper speed of 40 cm/mm (Linear
Instrument Co., Irvine, California).
After placing 20 pJ of cell suspension in the gap, the suspen-
sion is sheared at 460 sec1 for 30 sec to disperse all RBC
aggregates. The drive motor is then instantly stopped and the
light transmission abruptly drops due to a transient state of
random cellular orientation [28]. Following this rapid drop, the
transmission increases with time, t, at a rate proportional to the
rate of RBC aggregation (that is, at a rate proportional to the
formation of cell-free liquid gaps between aggregates). To
obtain an index of the rate of increase of light transmission, the
portion of the curve after the transient drop is manually
differentiated, and the resulting data is plotted semi-logarithmi-
cally as ln(dV/dt) versus time. The slope of the resulting straight
line is obtained by least squares linear regression and the
aggregation half time (AHT) calculated from this slope as:
AHT, sec = —ln 2/slope. Note that the AHT decreases with
more rapid rates of aggregation. AHT was determined in
triplicate for each suspension and the mean value of these
measurements used for the suspension; the coefficient of varia-
tion of these individual measurements was found to be less than
10%.
Zeta sedimentation ratio (ZSR). The degree of RBC aggrega-
tion following a defined 3-mm period of low gravity (7 to 8 g)
dispersion and compaction was determined using the zeta
sedimentation ratio method of Bull and Brailsford [20]. Well-
mixed cell suspensions are introduced into 75 mm long by 2.0
mm ID glass tubes, placed in the Zetafuge (Coulter Electronics,
Hialeah, Florida) and rotated, in a nearly vertical position, for
four 45-sec periods; the tubes are rotated 180° parallel to their
long axis at the end of each 45-sec period. As with the usual
ESR technique, cell aggregation causes the RBC-suspending
medium interface to move toward the bottom of the tube. The
"hematocrit" of the suspension, read after the 3-mm period, is
termed the "Zetacrit." The true hematocrit of the suspension in
the tube is then determined using a conventional microhemato-
crit centrifuge and the zeta sedimentation ratio (ZSR) calculated
as the ratio of the true hematocrit to the zetacrit. Note that,
unlike the AHT, the value of the ZSR increases with increasing
RBC aggregation [20, 22]. Inasmuch as preliminary replicate
measurements with the Zetafuge indicated coefficients of varia-
tion of less than 1.0%, the ZSR was determined only once for
each suspension.
Microscopic aggregation index (MAI). The steady state
extent of RBC aggregation at the end of a 10-mm period of stasis
was measured by the microscopic aggregation index (MAT)
method described by Chien et al [26]. Two 0.7% hematocrit
RBC samples (one RBC suspended in PBS, the other in the
medium under study) are placed in opposite chambers of a
standard 10O- thick hemocytometer and inspected with normal
microscope-video methods 10 mm after loading the samples.
The number of particles in an equal volume is counted for each
chamber, with the particle count independent of the number of
RBC in each particle (that is, an individual RBC or a multi-cell
rouleaux each count as one particle). The microscopic aggrega-
tion index (MAI) was calculated as the ratio of the number of
particles in PBS (no aggregation) to the number of particles in
the aggregating medium (for example, plasma) and has a value
of unity in the absence of aggregation. Note that like the ZSR,
the value of MAT increases with increasing RBC aggregation.
Only one MAI determination was made per sample.
Miscellaneous techniques
The hematocrits of RBC suspensions were determined using
the microhematocrit technique; tubes were spun for 4 mm in an
IEC-MB centrifuge (International Equipment Co., Needham
Heights, Massachusetts). Solution osmolalities were measured
by freezing point depression (model 2007, Precision Systems,
Sudbury, Massachusetts) and pH by a Radiometer system
operating at 25°C (Radiometer Co., Copenhagen, Denmark).
Plasma fibrinogen levels were measured via a radial-immunodif-
fusion technique (M-Partigen Fibrinogen Kit, CalbiochemBeh-
ring Co., La Jolla, California).
Plasma viscosities in centipoise (cp) were determined at 25°C
using a model 1/2 RVT-200 Wells-Brookfield Micro Cone-Plate
Viscometer (Brookfield Engineering Laboratories, Stoughton,
Massachusetts). The viscosity of each sample was determined
at 300, 750, and 1500 sec, and the mean of these three values
was assigned to the samples. In agreement with other investiga-
tions [15, 291, all plasma samples were found to be Newtonian
and showed no variation of viscosity with shear rate. The
viscometer was calibrated by use of standard oils of known
viscosity (Cannon Instrument Co., State College,
Pennsylvania).
Results
Dealing initially with red cell aggregation behavior in autolo-
gous plasma, Table 2 presents a summary for the 21 nephrotic
patients and the 18 control donors. Examination of the data
leads to the following observations: (1) The rate of RBC
aggregation, as measured by the AHT method, is greater for the
NS patients. The 39% decrease in the NS AHT is significant at
the P < 0.001 level. (2) The degree of RBC aggregation, as
judged by the magnitude of the ZSR, is also greater for the NS
patients. The 25% increase in ZSR for the NS group is again
significant at the P < 0.001 level. (3) The steady state extent of
cellular aggregation, as determined by the MAI technique, is
not significantly different between the NS and the control
groups (0.10 > P > 0.05). Also shown in Table 2 are the plasma
viscosity values and the plasma fibrinogen concentrations for
the NS and the control groups. Fibrinogen levels were signifi-
cantly (P < 0.001) elevated in the NS group, whereas no
significant difference in plasma viscosity was detected (0.20 > P
> 0.10). The significant differences noted for AHT, ZSR, and
plasma fibrinogen levels (Table 1) were not found to be a
function of renal insufficiency; no meaningful differences were
found between the two subgroups of NS patients. Moreover,
there were no correlations between AHT, ZSR, or fibrinogen
levels and serum creatinine concentration.
AHT and ZSR results in autologous plasma demonstrated a
significant cross-correlation for the 21 NS patients (AHT =
—3.97(ZSR) + 3.64, r = —0.76, P < 0.001) whereas a weaker
correlation was found for the 18 control donors (AHT =
—l2.l(ZSR) + 7.94, r = —0.44,0.05 > P >0.02). Pooling of the
control and NS data (that is, 39 data pairs) also resulted in a
significant correlation (AHT = —5.02(ZSR) + 4.33, r = —0.68,
P <0.001). No meaningful relationships were found between
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Table 2. RBC aggregation behavior in autologous plasma, fibrinogen levels, and plasma viscosities for NS patients and controlsa
Patients (N = 21) Controls (N = 18) P
AHT, sec 1.11 0.44 1.82 0.72 < 0.001
ZSR 0.64 0.08 0.51 0.03 < 0.001
MAI 3.01 0.84 2.63 0.41 0.10 > P> 0.05
Plasma viscosity, cp 1.75 0.34 1.64 0.08 0.20 > P > 0.10
Fibrinogen, g% 0.52 0Th
(Range, 0.26 to 1.28)
0.31 0.07
(Range, 0.17 to 0.48)
< 0.001
Abbreviations: AHT, aggregation half time; ZSR, zeta sedimentation ratio; MAI, microscopic aggregation index.
Results are expressed as mean so.
Fig. 1. Effect of plasma fibrinogen concentration on the rate of cellular
aggregation for RBC in autologous plasma. Note that the aggregation
half time decreases as the rate of aggregation increases. The straight
line was computed for the 21 NS data points. Symbols are: 0, controls;
•, nephrotic syndrome patients.
MAI and AHT or MAI and ZSR for NS patients, controls or
pooled data; P values always exceed 0.30.
The effect of plasma fibrinogen concentration on AHT is
shown in Figure 1. The straight line drawn was computed only
for the NS patients, since no significant correlation between
AHT and fibrinogen concentration was found for the control
donors (P > 0.30). The regression equation was ln(AHT)
—0.730 ln(fibrinogen concentration) — 0.502, with a correlation
coefficient of —0.75. The slope of the line is significantly
different from zero (P < 0.001), and the relationship suggests a
clear dependence of AHT on NS plasma fibrinogen concentra-
tion. For example, at 0.3 g% fibrinogen the computed AHT is
1.46 sec whereas at 1.0 g% fibrinogen, the computed AHT is
0.59 sec. Thus, there is an almost 60% decrease of AHT for this
threefold increase of fibrinogen concentration.
A significant relationship was also found between the ZSR of
NS RBC-plasma suspensions and their fibrinogen concentra-
tions. Figure 2 presents a plot of this data, where again the
0.
— 0.1 0.5 1.0 2.0
3.0
Fibrinogen concentration, g/d!
Fig. 2. Effect of plasma fibrinogen concentration on cellular aggrega-
tion for RBC in autologous plasma. Note that the zeta sedimentation
ratio increases with increasing cellular aggregation. The straight line
was computed for the 21 NS data points. Symbols are: 0, controls; S,
nephrotic syndrome patients.
straight line drawn was computed only for the NS patients; no
significant correlation was found between ZSR and fibrinogen
concentration for the control donors (P > 0.30). The equation
for the line is ZSR = 0.182 ln(fibrinogen concentration + 0.770,
with a correlation coefficient of 0.84; the slope of the line is
significantly different from zero (P < 0.001). Using this equa-
tion, the ZSR is 0.55 at 0.3 g% fibrinogen and 0.77 at 1.0 g%
fibrinogen or a 40% increase in ZSR for this threefold increase
of fibrinogen concentration.
Table 3 presents a summary of AHT and ZSR results for NS
or control RBC in the dextran-PBS solution and for the 0 Rh
positive RBC in NS or control plasmas. Examining first the
RBC-dextran solution data, it is clear that both types of RBC
aggregate equally in this medium since the small differences
shown for AHT and ZSR do not reach statistical significance.
Thus, the aggregating capacity of NS RBC do not differ from
control cells. Conversely, the studies employing 0 Rh positive
RBC in NS or control plasmas again demonstrate the increased
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Table 3. NS patient and control RBC aggregation in dextran and aggregation behavior of 0+ RBC resuspended in plasma (Mean SD)
RBC + Dextran 0+ RBC in p1asma from patients or controls
Patients Controls Patients Controls
AHT, sec 0.83 0.20
P>0.3
0.78 0.13 0.93 0.29
P<0.02
1.41 0.85
ZSR 0.75 0.03
P> 0.2
0.74 0.02 0.64 0.08
P< 0.001
0.51 0.03
aggregation caused by NS plasma. The 34% decrease of AHT
for these cells in NS plasma is significant (P < 0.02) as is the
25% increase of ZSR for these RBC in NS plasma (P < 0.001).
Discussion
The results of this study demonstrate that RBC aggregation in
autologous plasma, as measured by the AHT and ZSR methods,
is enhanced in nephrotic syndrome (Table 2) and that this
aggregation is significantly correlated with the elevated fibrino-
gen levels observed in these patients (Figs. I and 2). These
fibrinogen-aggregation results agree with the AHT studies of
Schmid-Schönbein et al [281, who showed that increased
amounts of exogenous fibrinogen added to RBC suspensions
caused a marked decrease in AHT. They also agree with
investigations in which elevated ZSR values were found to be
associated with fibrinogen-induced cellular aggregation [201.
Further, they are supported by a large body of rheologic data
which demonstrate a positive correlation between RBC aggre-
gation and fibrinogen concentration [14, 15, 30, 311. Since NS
RBC behave like control cells in an aggregating dextran solution
and since 0 Rh positive red cells exhibit greater aggregation in
NS plasma (Table 3), it seems clear that the increased RBC
aggregation observed in NS is due to the abnormal fibrinogen
levels seen in this disease. Note that while contributions from
other high molecular weight proteins (that is, macroglobulins)
are a possibility [25, 32], the correlation coefficients indicate
that from 56% (Fig. 1) to 71% (Fig. 2) of the deviations are
explained by the fibrinogen concentration.
The failure of the MAI technique to either detect differences
between NS patients and control donors (Table 2) or to demon-
strate a correlation with fibrinogen most likely results from the
high fibrinogen levels encountered in this study. In the original
publication detailing the MAI method, Chien et al [261 describe
aggregation results for RBC suspended in saline-fibrinogen
solutions. The MAI value was found to be 1.0 (that is, no
aggregation) below 0.2 g% fibrinogen, then increase until an
asymptotic limiting value was reached at or above 0.6 g%. More
recently, Chien et al [321 indicated that normal human plasma
produces RBC aggregation comparable to a 0.6 g% fibrinogen-
saline solution. Thus, increasing plasma fibrinogen concentra-
tion above the normal range would not further increase the MAI
but rather place the data on the nearly flat, asymptotic portion
of the curve where no correlation between fibrinogen and MAI
is to be expected.
The lack of correlation between the control AHT or ZSR data
and their associated plasma fibrinogen levels (Figs. 1 and 2)
appears to be due to the relatively narrow range of fibrinogen
concentration in these healthy individuals. Table 2 indicates a
22% coefficient of variation in this independent variable for the
controls, whereas a 44% coefficient of variation was observed
for the NS patients. It is interesting to note, however, that the
straight lines drawn in Figures 1 and 2 for the NS points do not
seem to be inappropriate for the control data values (in Fig. 1
the r value of —0.75 becomes —0.71 for the pooled patient and
control data whereas in Fig. 2 the r of 0.84 becomes 0.81 for the
pooled data). Thus, it is possible to speculate that the increased
cell aggregation noted in NS represents a fibrinogen-induced
enhancement of the normal RBC aggregation process.
The nonsignificant difference in plasma viscosity noted be-
tween the NS and control donors (Table 2) most likely reflects
the protein composition of these plasmas. The magnitude of
plasma viscosity is determined by the molecular size, shape,
and concentration of the proteins present [151 and is increased
more by a given increase of fibrinogen than by albumin. Since
NS is characterized by high fibrinogen levels and low albumin
concentrations [11, the contribution from fibrinogen appears to
be balanced by the lower albumin level.
The enhanced RBC aggregation found in this study suggests
that increased blood viscosity and altered blood flow behavior
should be associated with nephrotic syndrome. The rheological
properties of human blood have been studied by several investi-
gators [15, 16, 25, 261 using a variety of viscometric systems (for
example, tube, cone-plate or Couette viscometers). Salient
features of its rheological behavior include: (1) Normal blood
behaves as a non-Newtonian fluid, with viscosity increasing
with decreasing shear rate; (2) hematocrit influences both
viscosity and the degree of non-Newtonian behavior, so that at
and above the physiologic range, blood exhibits a non-linear
increase in viscosity with hematocrit and is markedly non-
Newtonian; (3) at constant hematocrit, increased RBC aggrega-
tion causes increased blood viscosity; (4) the extent of cellular
aggregation is an inverse and reversible function of shear rate,
such that RBC aggregates (that is, rouleaux) seen at stasis or at
low rates of shear are disrupted at high shear rates; (5)
fibrinogen is the plasma protein mainly responsible for RBC
aggregation and the non-Newtonian flow properties of blood.
The above-mentioned possible increase in blood viscosity
due to RBC aggregation, coupled with the high incidence of
deep vein thrombosis in NS [1—3], are consistent with investiga-
tions suggesting that altered blood rheology and blood flow may
be of importance in the development of venous thrombosis [33—
37]. Several model studies [37—401 have shown that platelet
deposition and residence time increase near a region of dis-
turbed flow and that the extent of this abnormal platelet
behavior is a function of the rheological properties of blood.
Further, the convective transport of relevant solutes (that is,
oxygen, ADP, thrombin) is also influenced by the rheology of
blood, such that increased RBC aggregation and thus increased
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blood viscosity reduces the rate of convective movement [10,
361. Areas of low oxygen tension or concentrated pro-coagu-
lants would be favored by increased blood viscosity, particular-
ly in regions of low and/or disturbed flow.
Fluid mechanical conditions favoring the development of
thrombosis exist in the venous circulation, where: (1) Blood
flow velocity is normally low and flow stasis can occur [411; (2)
the presence of venous valves provides the geometric basis for
flow disturbance [10, 421. Note that blood within venous valve
pockets can become hypoxic without convective mixing, with
the hypoxemia leading to thrombus formation on the valve cusp
[10, 12]. Note also that venous thrombi are preferentially
located in venous valves or regions of low blood flow such as
venous sinuses [4 1—431. In overview, our data provide addition-
al evidence to support the position [33, 34, 37, 39, 401 that the
non-Newtonian viscosity of blood, amplified by enhanced cellu-
lar aggregation, is an important factor in thrombogenesis.
Given the potential clinical implications of RBC aggregation
studies in NS as well as other pathologic states, it seems useful
to briefly comment on the general applicability of the three
methods used in this study. The AHT and ZSR methods have in
common the use of a normal hematocrit and thus a highly
crowded RBC suspension, but differ in the details of the fluid
mechanics occurring during aggregation and the time scale over
which aggregation is measured.
The AHT technique follows the aggregation process in a 30-pt
gap immediately after the fully dispersed suspension is brought
to a sudden stop. Light transmission is recorded for about 10 to
20 sec, but only the initial 2 to 5 sec portion of the data are fitted
to a straight line model for the estimation of the AHT. Thus, the
AHT index provides information on the very early phases of
aggregation [281 for aggregate formation at zero shear rate.
Conversely, cell aggregation in the ZSR method occurs in a
larger geometry system (2.0 mm ID tube), over a longer time
period (3 mm), from a somewhat undefined initial degree of
aggregation and is favored by the repeated cycles of low gravity
centrifugation (that is, low shear rate) which cause cell to cell
contact [201. Despite these differences, the AHT and ZSR data
demonstrated significant cross-correlation (r = —0.76 for the 21
NS patients, r = —0.68 for the pooled NS and control results),
thus indicating that the two approaches provide similar informa-
tion on the RBC aggregation process. Note that since stasis and
low flow velocities (that is, low shear rates) are normal features
of venous circulation [411, both the AHT and ZSR methods
appear to be appropriate for studies of RBC aggregation rele-
vant to in vivo conditions. In practice, however, the lower cost
and less complex operation of the ZSR suggest this method for
routine evaluation of RBC aggregation; the AHT and similar
light transmission techniques are advantageous when more
detailed information on the aggregation process is required.
Finally, the MAI method seems inappropriate for strongly
aggregating systems (that is, high plasma fibrinogen concentra-
tions) and thus more useful for evaluating RBC suspensions of
decreased aggregating tendency (Linderkamp, Ozanne, and
Meiselman, in preparation).
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